Connection

L. W. Church to Vaccines, Attenuated

Back to Details
This is a "connection" page, showing publications L. W. Church has written about Vaccines, Attenuated.
L. W. Church
Connection Strength
0.051
Vaccines, Attenuated
  1. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.
    View in: PubMed
    Score: 0.039
  2. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002 Apr 15; 185(8):1155-64.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.